Delivery Order SPE2D018D0006-SPE2D325F473E
- Not listed
- This is a federal contract award to Eagle Pharmaceuticals, Inc., a specialized pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia in high-risk patients. The contract award, with a ceiling value of $10,161.24, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 29, 2024. This award is not...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
- The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of the drug Ryanodex. The contract has a ceiling value of $132,251.39 and an ultimate completion date of April 8, 2024. Ryanodex is a critical medication used for the treatment and prevention of malignant hyperthermia in high-risk patients, primarily for military healthcare operations....
- This federal contract award, valued at $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The contract is for the delivery of Ryanodex 250mg vials, a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a performance period ending on February 28, 2025. This award is part of a larger Federal Supply Schedule...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
- This federal contract award is a delivery order (SPE2D018D0006|SPE2D325F5039) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals"), a for-profit pharmaceutical manufacturer. The contract, valued at $5,292.66, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set-aside and is part of a larger...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 delivery order for 4561342151 RYANODEX 250 MG VIAL under a firm fixed price contract. Performance will take place in Westwood, New Jersey from June 23, 2023 through June 28, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies, indicating this delivery order is...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $4,874.13 delivery order for 4561566809 RYANODEX 250 MG VIAL under a firm fixed price contract. Performance will take place in Westwood, New Jersey from July 21, 2023 through July 26, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical commodities, indicating this delivery order is...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $4,874.13 delivery order for 4561566807 RYANODEX 250 MG VIAL under a firm fixed price contract. Performance will take place in Westwood, New Jersey from July 21, 2023 through July 26, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical commodities, indicating this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $1,605.44 and an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2D018D0006Indefinite Delivery Contract
- SPE2D018D0006-SPE2D325F473EDelivery Order
The Defense Logistics Agency Troop Support Medical awarded a delivery order contract valued at $7,056.88 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. The contract was awarded on September 30, 2025, with an ultimate completion date of October 3, 2025, and operates under a firm fixed price structure with no set-aside designation. Performance will occur at Eagle Pharmaceuticals' facility in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which is valued at approximately $30.9 million and runs through January 2029, enabling efficient procurement of pharmaceutical products across federal medical supply chains. Ryanodex is a specialized injectable medication used to treat and prevent malignant hyperthermia, a rare but life-threatening pharmacogenetic disorder. Eagle Pharmaceuticals, headquartered in Woodcliff Lake, New Jersey, serves as a critical supplier of specialized pharmaceutical products to the Department of Defense and Department of Veterans Affairs. The company has consistently received delivery order awards through the DLA for Ryanodex supply, supporting medical readiness initiatives across federal healthcare infrastructure. This particular delivery order represents a routine procurement of essential medical supplies to maintain adequate inventory levels within the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/30/25 |